Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 5—May 2004


Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*Comments to Author , and Pan-Chyr Yang*
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan

Main Article

Table 2

Initial laboratory data of 76 patients with SARSa

Laboratory parameters
(normal range) Mean ± standard deviation No. (%) of patients with abnormal data
Leukocyte counts (4–9 x 109/L)
6.0 ± 2.9


15 (19.7)

49 (64.5)
  Platelet counts (150–450 X 109/L)


35 (46.1)
AST (<35 U/L)
24c (35.3)
ALT (<35 U/L)
11d (23.9)
LDH (<460 U/L)
9e (56.3)
CK (<190 U/L)
17f (26.1)
CRP (<0.8 mg/dL) 3.9±3.6 53g (77.9)

aSARS, severe acute respiratory syndrome; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK, creatine kinase; CRP, C-reactive protein.
bDefined as <1 X 109/L.
cOnly 68 patients had been tested.
dOnly 46 patients had been tested.
eOnly 16 patients had been tested.
fOnly 65 patients had been tested.
gOnly 68 patients had been tested.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO